Statistically significant reduction in general well-being by a first-choice combined oral contraceptive pill (150 μg levonorgestrel and 30 μg ethinylestradiol) in comparison with placebo in healthy women, based on a double-blind, randomized, placebo-controlled trial.

See the source article by following the link below:
Statistically significant reduction in general well-being by a first-choice combined oral contraceptive pill (150 μg levonorgestrel and 30 μg ethinylestradiol) in comparison with placebo in healthy women, based on a double-blind, randomized, placebo-controlled trial.